Science & Technology

The latest in science and technology.

McGill bioethicists argue for stricter limits on first-in-human clinical trials

The standards for drugs entering first-in-human (FIH) clinical trials are too low, argues Associate Professor Dr. Jonathan Kimmelman and PhD candidate Carole Federico in McGill’s Biomedical Ethics Unit. In a commentary published online in Nature on Jan. 30, Kimmelman and Federico maintain that evidence for drug efficacy is not emphasized enough before[Read More…]

McGill-led company, Carbicrete, designs carbon neutral concrete

The process of manufacturing cement—the primary material used in the production of concrete—accounts for five per cent of the world’s carbon dioxide emissions. The emissions from cement production are unsustainable at the planet’s current rate of development. However, Carbicrete, a McGill-led technology company, has developed patented technology that not only[Read More…]

Read the latest issue

Read the latest issue